Logo
Please use this identifier to cite or link to this item: http://20.198.91.3:8080/jspui/handle/123456789/2057
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorMajumder, Arghya-
dc.contributor.advisorSamanta, Amalesh-
dc.contributor.advisorChatterjee, Sharmila-
dc.contributor.authorMukherjee, Alankar-
dc.date.accessioned2023-03-01T08:16:28Z-
dc.date.available2023-03-01T08:16:28Z-
dc.date.issued2019-
dc.date.submitted2019-
dc.identifier.otherDC4514-
dc.identifier.urihttp://20.198.91.3:8080/jspui/handle/123456789/2057-
dc.format.extent[vii], 66 p.en_US
dc.language.isoenen_US
dc.publisherJadavpur Univesity, Kolkata, West Bengalen_US
dc.subjectChronic kidney disease (CKD)en_US
dc.subjectErythropoietin (EPO)en_US
dc.subjectHemodialysisen_US
dc.titlePattern of use of various erythropoiesis stimulating agents in hemodialysis patientsen_US
dc.typeTexten_US
dc.departmentJadavpur University. Department of Pharmaceutical Technologyen_US
Appears in Collections:Dissertations

Files in This Item:
File Description SizeFormat 
M.Pharm. (Pharmaceutical Technology) Alankar Mukherjee.pdf2.11 MBAdobe PDFView/Open


Items in IR@JU are protected by copyright, with all rights reserved, unless otherwise indicated.